Nishio_2015_Diabetes.Metab.Syndr.Obes_8_163

Reference

Title : Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability - Nishio_2015_Diabetes.Metab.Syndr.Obes_8_163
Author(s) : Nishio S , Abe M , Ito H
Ref : Diabetes Metab Syndr Obes , 8 :163 , 2015
Abstract : Nishio_2015_Diabetes.Metab.Syndr.Obes_8_163
ESTHER : Nishio_2015_Diabetes.Metab.Syndr.Obes_8_163
PubMedSearch : Nishio_2015_Diabetes.Metab.Syndr.Obes_8_163
PubMedID: 25834461

Related information

Citations formats

Nishio S, Abe M, Ito H (2015)
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
Diabetes Metab Syndr Obes 8 :163

Nishio S, Abe M, Ito H (2015)
Diabetes Metab Syndr Obes 8 :163